News
Most Read

Montreal Heart Institute reports positive results from Covid-19 trial
Telemedicine to benefit the most from remote patient monitoring tools: Poll
NIH reports full-dose blood thinners improve Covid-19 outcome

Most Recent

Clinical Trials

Montreal Heart Institute reports positive results from Covid-19 trial

25 Jan 2021
Analysis
Sections

Features
Comment
Projects
Most Read

Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy
Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market
Novo Nordisk’s makes strides into Alzheimer’s with anti-diabetic drug

Most Recent

Clinical Trials

Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

12 Jan 2021
Sectors
Sections

Clinical Trials
Approvals
Clinical Research
Operations
Outsourcing
Supply Chain
Cold Chain
Data Management
Medical Devices
Most Read

Delaying Covid-19 vaccine booster rooted in some clinical data versus reducing doses, but neither approach likely to solve distribution quandaries
Montreal Heart Institute reports positive results from Covid-19 trial
Phase II Trial of Anti-Amyloid AR1001 Signals Little Promise for Patients with Alzheimer’s Disease

Most Recent

Supply Chain

Delaying Covid-19 vaccine booster rooted in some clinical data versus reducing doses, but neither approach likely to solve distribution quandaries

27 Jan 2021
Themes
Deals
Most Read

Investment firm GI Partners closes Clinical Ink acquisition
Investment firm GI Partners to acquire minority interest in Clinical Ink
IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

Most Recent

Clinical Trials

Investment firm GI Partners closes Clinical Ink acquisition

27 Aug 2020
Companies
Sections

Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Most Read

Linari NanoTech
OpenClinica
Strategikon Pharma

Most Recent

Linari NanoTech

19 Jan 2021
Magazine
Events

Menu

News
Analysis
Investment
Sectors
Deals
Tech
Disruption
Coronavirus

Partners

Accelerating Clinical Trials
Simplifying Clinical Trials

Tools

Companies
Awards
Events
Magazine

The Company

About Us
Contact Us
Advertise With Us
Visit GlobalData

Login
Register

Login
Register

Increased Development of Targeted Therapies in the Neuroendocrine Tumors Pipeline Promises a Shift in the Standard of Care

Powered by

About Us
Editorial Approach
Contact Us
Terms and Conditions
Privacy Policy

© Copyright 2021 Verdict Media Limited.

Lost Password Back ⟶
Login
Register

Lost Password?

Registration is disabled.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Continue Learn more